ENTX

Conviction 49HealthcareScan · Thu, Jun 25, 2026

ENTX$1.45-5.84%

ResistanceSupportVol 14

Vol MA14 3.97M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Entera Bio Ltd.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.enterabio.com ↗

Price1.45

Change-5.84%

Gap-2.27%

Rel volume0.12×

Avg volume2.81M

Avg $ vol4.15M

SMA 201.28

SMA 501.24

SMA 2001.69

Price vs 50+16.88%

Price vs 200-14.07%

MA stackmixed

50/200 cross—

Supertrendup · 1.35

RSI (14)61

MACD hist0.03

MACD crossbull · 3d

Stoch %K / %D18 / 22

ADX (14)31

+DI / −DI56 / 4

RSI divergence—

MACD divergence—

ATR %+12.84%

ADR %11.79%

52w high3.14

52w low1.00

From 52w high-53.82%

Above 52w low+45.00%

New 52w highNo

SqueezeOff

Bollinger width38.47%

%B0.86

Donchian pos18.41%

Donchian high2.78

Donchian low1.15

AVWAP (52w high)1.71

vs AVWAP high-15.26%

AVWAP (52w low)1.73

vs AVWAP low-16.40%

OBV trendUp

Chaikin MF (20)-0.60

Today vs 20d0.12×

Avg vol (14d)3.97M

Avg vol (20d)2.81M

Avg $ vol (20d)4.15M

Market cap71.38M

RS 3m (vs SPY)+37.26%

RS 6m (vs SPY)-20.73%

RS line new highNo

Trend template3/8

Technical rank45.1

1 week+20.83%

1 month+19.83%

3 months+22.88%

6 months-22.87%

1 year-26.02%

YTD-18.08%

P/E-6.24

P/B6.68

P/S—

P/FCF-9.55

EPS0.2500

Div yield—

ROE-107.04%

ROA-87.13%

Debt/Eq—

Current7.93

EV/EBITDA—

Gross margin0.00%

Net margin—

Rev growth-76.80%

EPS growth-19.89%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value67.24M

Revenue0

Net income-3.5M

Gross profit0

Free cash flow-7.48M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out49.29M

Employees22

ListedThu, Jun 28, 2018

Free float25.65M

Float %55.0%

Short interest177.67K

Days to cover2.3d

Short volume43.3%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank45.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.08

Support1.11

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ENTX

All disclosures →

No recent disclosed trades by Congress in ENTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ENTX · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Galitzer Hillel Chief Operating Officer · Ordinary Shares, par value NIS 0.0000769 per share · 2026-05-07	Grant	72.99K	$0	2026-05-07	2026-05-08
Burshtein Gregory Chief of R&D · Ordinary Shares, par value NIS 0.0000769 per share · 2026-05-07	Grant	87.59K	$0	2026-05-07	2026-05-08
Yaacov-Garbeli Dana Chief Financial Officer · Ordinary Shares, par value NIS 0.0000769 per share · 2026-05-07	Grant	58.39K	$0	2026-05-07	2026-05-08

SEC filings

EDGAR filings in ENTX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.